Fitch also affirmed the “A” rating on Stamford’s $250 million of series 2012J bonds and $110 million of series 2010I bonds.
The rating assignment and affirmation are based on several factors, including Stamford’s leading market share. Stamford also faces numerous challenges, including profitability that has been lower than initially projected over the past two years.
The outlook is stable.
More articles on healthcare finance:
Most ACA enrollees happy with coverage, but increasingly concerned about deductibles, premiums
Consumer advocate: Oregon price estimate pledge doesn’t protect all patients
Google bans payday loan ads, flagged as ‘dangerous product’
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
